SCHEMBL19960656

SCHEMBL19960656

O=C1Cc2ccccc2C(C(=O)N2C(=O)OCC2Cc2ccccc2)N1CC1CC1

nearest known ligand 0.47

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GRM7 Q14831 1/20 0.47
PPARA Q07869 2/20 0.37
IDH1 O75874 11/20 0.36
NAAA Q02083 1/20 0.35
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
HDAC1 Q13547 2/20 0.33
FAAH O00519 1/20 0.33
DAGLA Q9Y4D2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960508 1.00 GRM7 (0.47) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL19960655 1.00 GRM7 (0.47) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL20112962 1.00 GRM7 (0.47) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL19960662 0.85 NAAA (0.36) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL19960657 0.85 NAAA (0.36) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL20113023 0.85 NAAA (0.36) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL20113018 0.85 NAAA (0.36) GRM7PPARAIDH1NAAACSNK2B
SCHEMBL21559917 0.82 GRM7 (0.37) GRM7PPARAIDH1
SCHEMBL19960659 0.78 NAAA (0.39) GRM7PPARANAAACSNK2BCSNK2A1
SCHEMBL19953496 0.76 GRM7 (0.61) GRM7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541812-B1 MGLUR7 AGONIST COMPOUNDS FOR TREATING MGLUR7- REGULATED DISEASES, DISORDERS, OR CONDITIONS TAKEDA PHARMACEUTICALS CO (JP) 2023-06-14 EP disclosed
WO-2018079862-A1 MGLUR7 MODULATORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-05-03 WO disclosed
WO-2018047983-A1 INDANE DERIVATIVES USEFUL AS MODULATORS OF MGLUR7 TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-03-15 WO disclosed